NCT06743100 2025-04-0218F-Floretyrosine Expanded Access ProgramTelix Pharmaceuticals (Innovations) Pty LimitedAvailable
NCT05356312 2024-03-01Glioblastoma and Individualized TherapiesZentrum fur Humangenetik TuebingenAvailable